Indications for the use of bispecific antibodies (BsAbs) are rapidly increasing in oncology. While many cancer centers are keeping an eye on this developing field, curiosity must be transformed into proactive planning to avoid being caught unprepared as BsAb indications expand. In this episode, CANCER BUZZ speaks with Laura Kuzma, MSW, admin administrative director of FirstHealth Cancer Center and Oncology Services at FirstHealth Moore Regional Hospital, about the real-world lessons she has learned about governance considerations, ramp-up strategies, and workflows. She shares the importance of proactively building workflows, readiness plans, and cross-team communication pathways to safely operationalize BsAb therapy.
“That was the biggest hesitancy: are we equipped to manage this type of care in this type of setting?”
“My request to the hospital administrators was to allow me to put together a team across the hospital to fully explore the financial side as well as the medical management side.”
“We had doctors in every area of the hospital on this. They cared about it, and I think it was exciting to them too. They felt like they were doing something meaningful, and their input was taken seriously.”
Guest:
Laura Kuzma, MSW
Administrative Director, Oncology Services and Clinical Trials
FirstHealth Moore Regional Hospital
Pinehurst, NC
Resources:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
Decentralized clinical trial approaches, including remote consent, telehealth, local laboratory and imaging services, and more, can help reduce some of the many barriers that prevent eligible patients from participating in trials. But as the participants in ACCC’s Advancing Decentralized Clinical Trials in the Community Setting Roundtable Series emphasized, implementing DCT elements is not simply a matter of adopting new technology. Doing so successfully requires thoughtful workflows and oversight structures that consider equity, scalability, and sustainability.
